Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yasmin Fardghassemi"'
Publikováno v:
Disease Models & Mechanisms, Vol 10, Iss 12, Pp 1465-1480 (2017)
Polyglutamine expansion diseases are a group of hereditary neurodegenerative disorders that develop when a CAG repeat in the causative genes is unstably expanded above a certain threshold. The expansion of trinucleotide CAG repeats causes hereditary
Externí odkaz:
https://doaj.org/article/29fd4f1f360644e3883b87339472b668
Publikováno v:
Neurotherapeutics
Spinocerebellar ataxia type 3 (SCA3), also known as Machado-Joseph disease (MJD), is a polyglutamine expansion disease arising from a trinucleotide CAG repeat expansion in exon 10 of the gene ATXN3. There are no effective pharmacological treatments f
Autor:
J. Alex Parker, Yasmin Fardghassemi
Publikováno v:
Experimental neurology. 337
Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is the most common form of dominantly inherited ataxia worldwide. This disease is caused by an expanded CAG repeat in the coding region of ATXN3. Due to our incomplete
Publikováno v:
Experimental Neurology. 293:101-114
Autism spectrum disorder (ASD) is the most common neurodevelopmental disorder with a constantly increasing prevalence. Model organisms may be tools to identify underlying cellular and molecular mechanisms, as well as aid the discovery and development
Publikováno v:
Disease Models & Mechanisms.
Background: Polyglutamine expansion diseases are a group of hereditary neurodegenerative disorders that develop when a CAG repeat in the causative genes are unstably expanded above a certain threshold. The expansion of trinucleotide CAG repeats cause
Autor:
Pierre Drapeau, Carl Julien, Alaura Androschuk, Clement Wong, Joel C. Strautman, Francois V. Bolduc, Cory Rosenfelt, Alexandra Lissouba, J. Alex Parker, Yasmin Fardghassemi, Surya Madabattula, Andrew M. Bysice, Guy A. Rouleau, Julia O'Sullivan
Publikováno v:
Human molecular genetics. 25(6)
Hereditary spastic paraplegias (HSPs) are a group of neurodegenerative diseases causing progressive gait dysfunction. Over 50 genes have now been associated with HSP. Despite the recent explosion in genetic knowledge, HSP remains without pharmacologi